L. Tomio

Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

Adriano Paccagnella, Antonio Orlando, C. Marchiori et al. · JNCI Journal of the National Cancer Institute · 1994 · 420 citations

Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo

G. Jori, Mariano Beltramini, Elena Reddi et al. · Cancer Letters · 1984 · 191 citations

Biochemistry, Major Role, Physiology +11

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

P. L. Zorat, A. Paccagnella, G Cavaniglia et al. · JNCI Journal of the National Cancer Institute · 2004 · 186 citations · Full text

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian et al. · Annals of Oncology · 2009 · 185 citations · Full text

Advanced Head, Neuro-oncology, Phase Ii +10

Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice

G. Jori, Elena Reddi, I. Cozzani et al. · British Journal of Cancer · 1986 · 78 citations · Full text

Tumour-bearing Mice, Drug Targeting, Medicine +9